Search results
Results From The WOW.Com Content Network
Though secondary osteoporosis is a separate category when it comes to osteoporosis diagnosis, it can still be a contributing factor to primary osteoporosis. Secondary osteoporosis can be present in pre- and post-menopausal women and in men and have found to be factors contributing to osteoporosis in both sexes (50-80% of men and 30% of post ...
The US National Osteoporosis Foundation recommends pharmacologic treatment for patients with hip or spine fracture thought to be related to osteoporosis, those with BMD 2.5 SD or more below the young normal mean (T-score -2.5 or below), and those with BMD between 1 and 2.5 SD below normal mean whose 10-year risk, using FRAX, for hip fracture is ...
Diabetes mellitus, deep voice, hirsutism, clitoral hypertrophy, adrenal cortical hyperplasia or adenoma amenorrhoea, hypertension and osteoporosis. [1] Usual onset: Post menopausal. [2] Diagnostic method: Clinical findings. [2] Differential diagnosis: Acquired adrenogenital syndrome, empty sella syndrome, diabetes, and polycystic ovary syndrome ...
[15] [16] Estrogen deficiency plays an important role in osteoporosis development for both genders, and it is more pronounced for women and at younger (menopausal) ages by five to ten years compared with men. Females are also at higher risk for osteopenia and osteoporosis. [16]
There are several kinds of kyphosis (ICD-10 codes are provided): Postural kyphosis (M40.0), the most common type, normally attributed to slouching, can occur in both the old [7] and the young. In the young, it can be called "slouching" and is reversible by correcting muscular imbalances.
As of 2014, The National Osteoporosis Foundation (NOF) recommends pharmaceutical treatment for osteopenic postmenopausal women and men over 50 with FRAX hip fracture probability of >3% or FRAX MOF probability >20%. [40] As of 2016, the American Association of Clinical Endocrinologists and the American College of Endocrinology agree. [41]
Bone resorption rates are much higher in post-menopausal older women due to estrogen deficiency related with menopause. [7] Common treatments include drugs that increase bone mineral density. Bisphosphonates , RANKL inhibitors , SERMs— selective oestrogen receptor modulators , hormone replacement therapy and calcitonin are some of the common ...
The effect is not limited to women who have oophorectomy performed before menopause; an impact on survival is expected even for surgeries performed up to the age of 65. [27] Surgery at age 50-54 reduces the probability of survival until age 80 by 8% (from 62% to 54% survival), surgery at age 55-59 by 4%.